Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Research Biosimilar

Research Grade Crefmirlimab (DHK18501)

Host species:Humanized
Isotype:(scFv-kappa-heavy) -h- CH3
Applications:Research Grade Biosimilar
Expression system:Mammalian Cells
Overview

Catalog No.

DHK18501

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Humanized

Isotype

(scFv-kappa-heavy) -h- CH3

Clonality

Monoclonal

Target

T-cell surface glycoprotein CD8 alpha chain, CD8a, T-lymphocyte differentiation antigen T8/Leu-2, MAL, CD8A

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Purified by Ion Exchange Chromatography.

Accession

P01732

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

89Zr-IAB22M2C, IAB22M2C, 89Zr-Df-IAB22M2C, CAS: 2611099-93-3

Clone ID

Crefmirlimab

Data Image
  • Bioactivity
    Detects CD8A in indirect ELISAs.
References
Datasheet

Document Download

Research Grade Crefmirlimab.pdf

 

$ 426
Product specifications
100 μg 426 1 mg 1704

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Research Grade Crefmirlimab [DHK18501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2024 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only